Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0002124509-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 14, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
34,174
Total Value
$3,468,590.73
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Global Commercialization Officer | Common Stock | โ | Sep 10, 2026 | Exercise/Conversion | 9,363 | $33.62 | $314,784.06 | 59,338 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Sep 10, 2026 | Sale | 6,019 | $203.28 | $1,223,568.80 | 53,319 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Sep 10, 2026 | Sale | 5,530 | $204.14 | $1,128,870.42 | 47,789 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Sep 10, 2026 | Sale | 2,420 | $205.05 | $496,224.15 | 45,369 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Sep 10, 2026 | Sale | 1,179 | $206.10 | $242,991.31 | 44,190 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Sep 10, 2026 | Sale | 300 | $207.17 | $62,151.99 | 43,890 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Stock Option (Right to Buy) | Derivative | Sep 10, 2026 | Exercise/Conversion | 9,363 | $0.00 | $0.00 | 96,746 | Direct | โ | View Details |